The Disruptors: The Biologic Revolution in Radiotherapies

Moderator

John Bishai, PhD

Global Healthcare Investment Banking, BofA Securities

Panelists

Amos Hedt

Chief Business Strategy Officer, Perspective Therapeutics

Lana Janes, PhD

Chief Operating Officer, Abdera Therapeutics

Philip Kantoff, MD

Co-Founder & CEO, Convergent Therapeutics

Matthew Roden, PhD

President & CEO, Aktis Oncology

Matt Vincent, PhD

Chief Business Officer, AdvanCell Isotopes

Picasso Ballroom